Cargando…

Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has become a pandemic, infecting more than 4,000,000 people worldwide. This review describes the main clinical features of COVID-19 and potential role of microbiota in COVID-19. SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yu, Wang, Jianhui, Li, Fang, Shi, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291771/ https://www.ncbi.nlm.nih.gov/pubmed/32582134 http://dx.doi.org/10.3389/fmicb.2020.01302

Ejemplares similares

Characterization of host substrates of SARS-CoV-2 main protease
por: Melano, Ivonne, et al.
Publicado: (2023)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
por: Liu, Mingtao, et al.
Publicado: (2023)

SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs
por: Min, Yuan-Qin, et al.
Publicado: (2020)

Insilico generation of novel ligands for the inhibition of SARS-CoV-2 main protease (3CL(pro)) using deep learning
por: Prabhakaran, Prejwal, et al.
Publicado: (2023)

Replication, pathogenicity, and transmission of SARS-CoV-2 in minks
por: Shuai, Lei, et al.
Publicado: (2020)

Nuclear translocation of spike mRNA and protein is a novel feature of SARS-CoV-2
por: Sattar, Sarah, et al.
Publicado: (2023)

SARS-CoV-2 and gastrointestinal diseases
por: Sha, Ailong, et al.
Publicado: (2023)

The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
por: Romani, Lorenza, et al.
Publicado: (2022)

Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota
por: Tieu, Vivian, et al.
Publicado: (2023)

Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection
por: Shi, Yong-Lin, et al.
Publicado: (2022)

Respiratory Microbial Co-infection With SARS-CoV-2
por: Massey, Bill W., et al.
Publicado: (2020)

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro
por: Clementi, Nicola, et al.
Publicado: (2020)

Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review
por: Jeong, Gi Uk, et al.
Publicado: (2020)

Evaluation of the presence of SARS-CoV-2 in vaginal and anal swabs of women with omicron variants of SARS-CoV-2 infection
por: Liu, Ding, et al.
Publicado: (2022)

Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2
por: Liu, Sheng, et al.
Publicado: (2020)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
por: Klasse, PJ, et al.
Publicado: (2020)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

The Potential Intermediate Hosts for SARS-CoV-2
por: Zhao, Jie, et al.
Publicado: (2020)

On the origin and continuing evolution of SARS-CoV-2
por: Tang, Xiaolu, et al.
Publicado: (2020)

Inferring the Main Drivers of SARS‐CoV‐2 Global Transmissibility by Feature Selection Methods
por: Djordjevic, Marko, et al.
Publicado: (2021)

Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths
por: Ortega, Miguel A., et al.
Publicado: (2022)

In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles
por: Bartas, Martin, et al.
Publicado: (2020)

Global Mutational Sweep of SARS-CoV-2: From Chaos to Order
por: Wang, Xin, et al.
Publicado: (2022)

Oral SARS-CoV-2 Spike Protein Recombinant Yeast Candidate Prompts Specific Antibody and Gut Microbiota Reconstruction in Mice
por: Zhang, Lilin, et al.
Publicado: (2022)

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
por: Sanachai, Kamonpan, et al.
Publicado: (2022)

Correlation between dissociation and catalysis of SARS-CoV main protease
por: Lin, Pei-Ying, et al.
Publicado: (2008)

Geographic and Genomic Distribution of SARS-CoV-2 Mutations
por: Mercatelli, Daniele, et al.
Publicado: (2020)

Mink, SARS-CoV-2, and the Human-Animal Interface
por: Fenollar, Florence, et al.
Publicado: (2021)

SARS-CoV-2 and Its Variants: The Pandemic of Unvaccinated
por: Angius, Fabrizio, et al.
Publicado: (2021)

Mapping Genetic Events of SARS-CoV-2 Variants
por: Qin, Luyao, et al.
Publicado: (2022)

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
por: Wang, Mei-Yue, et al.
Publicado: (2020)

Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection
por: Bao, Lirong, et al.
Publicado: (2020)

Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay
por: Drouot, Laurent, et al.
Publicado: (2020)

A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India
por: Bose, Tungadri, et al.
Publicado: (2023)

The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020)

Topological analysis of SARS CoV-2 main protease
por: Estrada, Ernesto
Publicado: (2020)

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ed4q1vub6io9a89dulhm0gk5qp